Aarkstore Enterprise Autoimmune Treatment (2009 - 2014)

Share:    

Autoimmune disorders result from an overactive immune response of a body working against its own cells

. The disease is broadly classified into two types: systemic autoimmune diseases, which affect several organs of the body; and localized autoimmune diseases, which affect only one organ. Around 80 autoimmune diseases are recognized under these two categories. The disease affected over 300 million people across the globe in 2009. No defined reasons have been discovered to date for the occurrence of the disorder. Women are more prone to autoimmune diseases, constituting 70%-75% of all autoimmune patients.

The overall market for the treatment of autoimmune disorders is analyzed into the submarkets for applications, products, services, and technologies. The global market for autoimmune disease treatments is estimated to be at $37.84 billion in 2009, and is growing at a CAGR of 12.7% from 2009 to 2014 to reach an estimated $68.81 billion in 2014. The effects of the global meltdown are given careful consideration when forecasting the market.

The application market is further classified into the treatment markets for systemic autoimmune diseases and localized autoimmune diseases. The applications market is dominated mostly by rheumatoid arthritis under the systemic disease segment, while multiple sclerosis is the major application market under the localized disease segment. These two disorders account for 75% of the total applications market. The other major diseases analysed under the application market are psoriasis, lupus, type I diabetes, inflammatory bowel disease, and thyroid disorders, which together account for 15%-20% of the global applications market.

The product market is classified on the basis of the drugs, diagnostic equipments, therapeutic and monitoring equipment. Drugs form the largest segment of the products market, with major drugs such as NSAID, DMARD, biologic DMARD, Avonex, Rebif, Copaxone, Betaseron, and 5-ASA. The services market consists of consultation and diagnosis, therapy and monitoring, and drug development. The wide and increasing prevalence of autoimmune diseases is boosting the drugs market along with the therapy and monitoring market; along with the fact that almost all autoimmune diseases are chronic and have no permanent cure.
Share:    

The drugs market is estimated to have a revenue of $24.38 billion in 2009, and it is growing with a CAGR of 12.5% from 2009 to 2014. The total services market with therapy and monitoring and drug development as the largest contributor is estimated to be at $9.31 billion in 2009 and it is growing at a CAGR of 14% from 2009 to 2014.

Scope of the Report

The report provides market overviews and forecasts as well as market drivers and restraints for the global autoimmune treatment market. In addition, it profiles the top forty market players and their respective autoimmune products. The report identifies and analyzes the market according to application markets for both systemic and localized autoimmune diseases, product markets, services market and technologies market.

Autoimmune Treatment Applications

Systemic autoimmune diseases rheumatoid arthritis, psoriasis, lupus, and other systemic autoimmune diseases.

Localized autoimmune diseases multiple sclerosis, inflammatory bowel disease, diabetes, thyroid, and other localized autoimmune diseases.

Autoimmune Treatment Products

Drugs, diagnostic equipment, therapeutic and monitoring equipment, and other products.

Autoimmune Treatment Services

Consultation & Diagnosis, Therapy & Monitoring, Drug Development, and other services.

Autoimmune Treatment Technologies

DMARD (disease-modifying anti-rheumatic drugs) and biologic DMARD therapy, Bridge therapy, Topical therapy, Phototherapy, Helminthic therapy, Fecal bacteriotherapy, Haematopoietic stem-cell transplantation, Recombinant technology

For more information please contact :

http://www.aarkstore.com/reports/Autoimmune-Treatment-2009-2014--27513.html

http://blogs.aarkstore.com/

From:Aarkstore Enterprise
Share:    

Contact: Neel

Email: press@aarkstore.com

URL: www.aarkstore.com

by:

POST COMMENT

Top 5 Reasons to Avoid Breast Enlargement Surgery Fee Schedule Establishes Coverage For Annual Wellness Visits For Medicare Patients Major Medical Health Insurance Desire to Conserve Hundreds In your Medicare Supplemental Insurance Plan? Medicare Supplement Insurance Charges Are Available To Some People Under Age 65 Alzheimerâ€?s Illness and Its Treatment Breast Reduction Surgery Visitor Medical Insurance – Compare and Buy Online Medical Insurance Agents Express Concern Over MLR Now You Can Obtain Visitor Medical Insurance Authorization Online! Gearing up for your breast implant surgery in Toronto Fuller Breasts Without Surgery - It Is Possible Medicare Supplemental Insurance Charges Available To Medicare Members With out Discrimination